Randall E. Millikan

Platinum-Based Chemotherapy for Variant Castrate-Resistant Prostate Cancer

Ana M. Aparicio, Andrea Harzstark, Paul G. Corn et al. · Clinical Cancer Research · 2013 · 456 citations · Full text

Phase I Trial of the Proteasome Inhibitor Bortezomib in Patients With Advanced Solid Tumors With Observations in Androgen-Independent Prostate Cancer

Christos N. Papandreou, Danai Daliani, Darrell Nix et al. · Journal of Clinical Oncology · 2004 · 436 citations · Full text

Bone-targeted therapy for advanced androgen-independent carcinoma of the prostate: a randomised phase II trial

Shi‐Ming Tu, Randall E. Millikan, Bayabel Mengistu et al. · The Lancet · 2001 · 395 citations

Urology, Surgical Oncology, Genitourinary Cancer +8

Multimodality Management of Urachal Carcinoma: The M. D. Anderson Cancer Center Experience

Arlene O. Siefker‐Radtke, Jason Gee, Yu Shen et al. · The Journal of Urology · 2003 · 301 citations

A Prognostic Gene Expression Signature in the Molecular Classification of Chemotherapy-naïve Urothelial Cancer is Predictive of Clinical Outcomes from Neoadjuvant Chemotherapy: A Phase 2 Trial of Dose-dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin with Bevacizumab in Urothelial Cancer

David J. McConkey, Woonyoung Choi, Yu Shen et al. · European Urology · 2015 · 275 citations · Full text

Urology, Genitourinary Cancer, Medicine +8